Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Myriad Genetics (MYGN) Other Non-Current Assets (2016 - 2025)

Historic Other Non-Current Assets for Myriad Genetics (MYGN) over the last 14 years, with Q3 2025 value amounting to $6.6 million.

  • Myriad Genetics' Other Non-Current Assets fell 6000.0% to $6.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.6 million, marking a year-over-year decrease of 6000.0%. This contributed to the annual value of $8.5 million for FY2024, which is 4480.52% down from last year.
  • Per Myriad Genetics' latest filing, its Other Non-Current Assets stood at $6.6 million for Q3 2025, which was down 6000.0% from $7.1 million recorded in Q2 2025.
  • Over the past 5 years, Myriad Genetics' Other Non-Current Assets peaked at $225.7 million during Q2 2021, and registered a low of $3.6 million during Q1 2021.
  • For the 5-year period, Myriad Genetics' Other Non-Current Assets averaged around $22.8 million, with its median value being $8.8 million (2022).
  • Per our database at Business Quant, Myriad Genetics' Other Non-Current Assets skyrocketed by 56666.67% in 2021 and then tumbled by 9610.1% in 2022.
  • Over the past 5 years, Myriad Genetics' Other Non-Current Assets (Quarter) stood at $8.3 million in 2021, then soared by 86.75% to $15.5 million in 2022, then decreased by 0.65% to $15.4 million in 2023, then crashed by 44.81% to $8.5 million in 2024, then dropped by 22.35% to $6.6 million in 2025.
  • Its last three reported values are $6.6 million in Q3 2025, $7.1 million for Q2 2025, and $7.7 million during Q1 2025.